In-vitro studies have demonstrated that resveratrol blocks the activation of human monoblastic leukemia cell transcription factors induced by P. gingivalis, and interfere with the NF-κβ signal pathway in a dose-dependent manner (54). The gene discussed is NFKB1; the disease is leukemia.